767 related articles for article (PubMed ID: 22385653)
21. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia.
Liew A; O'Brien T
Stem Cell Res Ther; 2012 Jul; 3(4):28. PubMed ID: 22846185
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model.
Khatab S; van Osch GJ; Kops N; Bastiaansen-Jenniskens YM; Bos PK; Verhaar JA; Bernsen MR; van Buul GM
Eur Cell Mater; 2018 Nov; 36():218-230. PubMed ID: 30398288
[TBL] [Abstract][Full Text] [Related]
24. Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease.
Ward MR; Abadeh A; Connelly KA
Stem Cells Transl Med; 2018 Jul; 7(7):543-550. PubMed ID: 29665255
[TBL] [Abstract][Full Text] [Related]
25. Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases.
Elshaer SL; Bahram SH; Rajashekar P; Gangaraju R; El-Remessy AB
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008675
[TBL] [Abstract][Full Text] [Related]
26. Electrospun fibers enhanced the paracrine signaling of mesenchymal stem cells for cartilage regeneration.
Kadir ND; Yang Z; Hassan A; Denslin V; Lee EH
Stem Cell Res Ther; 2021 Feb; 12(1):100. PubMed ID: 33536060
[TBL] [Abstract][Full Text] [Related]
27. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine.
L PK; Kandoi S; Misra R; S V; K R; Verma RS
Cytokine Growth Factor Rev; 2019 Apr; 46():1-9. PubMed ID: 30954374
[TBL] [Abstract][Full Text] [Related]
28. Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.
Bajetto A; Thellung S; Dellacasagrande I; Pagano A; Barbieri F; Florio T
Stem Cells Transl Med; 2020 Nov; 9(11):1310-1330. PubMed ID: 32543030
[TBL] [Abstract][Full Text] [Related]
29. Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect.
Kusuma GD; Carthew J; Lim R; Frith JE
Stem Cells Dev; 2017 May; 26(9):617-631. PubMed ID: 28186467
[TBL] [Abstract][Full Text] [Related]
30. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease.
Yun CW; Lee SH
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813471
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine.
Carvalho MM; Teixeira FG; Reis RL; Sousa N; Salgado AJ
Curr Stem Cell Res Ther; 2011 Sep; 6(3):221-8. PubMed ID: 21476975
[TBL] [Abstract][Full Text] [Related]
34. Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regeneration.
Zagoura D; Trohatou O; Makridakis M; Kollia A; Kokla N; Mokou M; Psaraki A; Eliopoulos AG; Vlahou A; Roubelakis MG
EBioMedicine; 2019 Jul; 45():542-552. PubMed ID: 31303498
[TBL] [Abstract][Full Text] [Related]
35. Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation.
Selich A; Zimmermann K; Tenspolde M; Dittrich-Breiholz O; von Kaisenberg C; Schambach A; Rothe M
Stem Cell Res Ther; 2019 Sep; 10(1):285. PubMed ID: 31547865
[TBL] [Abstract][Full Text] [Related]
36. Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease.
Griffin M; Greiser U; Barry F; O'Brien T; Ritter T
Discov Med; 2010 Mar; 9(46):219-23. PubMed ID: 20350488
[TBL] [Abstract][Full Text] [Related]
37. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles.
Gómez-Ferrer M; Villanueva-Badenas E; Sánchez-Sánchez R; Sánchez-López CM; Baquero MC; Sepúlveda P; Dorronsoro A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810359
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases.
Műzes G; Sipos F
Cells; 2022 Jul; 11(15):. PubMed ID: 35892597
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes.
Maumus M; Jorgensen C; Noël D
Biochimie; 2013 Dec; 95(12):2229-34. PubMed ID: 23685070
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells and immune disorders: from basic science to clinical transition.
Wang S; Zhu R; Li H; Li J; Han Q; Zhao RC
Front Med; 2019 Apr; 13(2):138-151. PubMed ID: 30062557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
